𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alcoholic Liver Disease: Evaluation of Natural History and Prognostic Factors

✍ Scribed by Steven Schenker


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
874 KB
Volume
4
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Alcoholic liver disease, i.e., hepatic dysfunction developing in individuals abusing ethanol and caused by it, is worldwide in distribution and affects adults of both sexes and all ages. Alcohol abuse may cause a wide spectrum of hepatic changes. In most individuals, it may result in fat accumulation in the liver with or without overt functional changes, but often with a change in various aspects of hepatic metabolism (i.e., induction of drug metabolism, changes in glucose homeostasis, etc.). In others, it may lead to alcoholic hepatitis and/or cirrhosis, usually with varying disturbances in hepatic function (1).

It is well established that the incidence of alcoholic cirrhosis and mortality from it are generally correlated with the amount and duration of ethanol abuse (1, 2). Still, despite the high incidence of alcoholism throughout the world, the incidence of cirrhosis in this population is low. In autopsy series, it seems to vary from 8.7 to 18% and in studies based on liver biopsy it ranges from 12 to 31% (2). Thus, with about 10 to 12 million alcoholics in the United States, one may project over a period of time about 1 to 2 million patients with alcoholic cirrhosis. Since many alcoholics do not develop overt cirrhosis but remain at the stage of fatty liver and/or alcoholic hepatitis (3), the prevalence of these hepatic lesions among ethanol abusers is bound to be much higher than overt cirrhosis. The validity of such estimates will depend obviously on the reliability of determining the incidence of alcohol abuse in a population (a well-known problem), on the amounts and duration of ethanol consumption and the impact on this of recent educational campaigns, cost of liquor, and other economic factors, on the development of new treatment modalities and other imponderables. Among the latter unknown factors may be the


πŸ“œ SIMILAR VOLUMES


Liver transplantation for alcoholic live
✍ A C Anand; B H Ferraz-Neto; P Nightingale; D F Mirza; A C White; P McMaster; J M πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 216 KB πŸ‘ 1 views

We have used a formal transplant protocol to select patients with alcoholic liver disease (ALD) for transplantation. We retrospectively analyzed all the patients with ALD who were referred specifically for transplantation to our Liver Unit between 1987 and 1994. Patients were selected for liver tran

Cutaneous malignant melanoma. II. The na
✍ Donald H. Berdeaux; Frank L. Meyskens Jr; Bruce Parks; Tony Tong; Lois Loescher; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 722 KB

The survival history of 259 patients with Stage I cutaneous malignant melanoma who were at risk for developing regional nodal metastases (Stage 11) were studied. Eighty-seven of 377 Stage I patients (23%) developed regional nodal metastases (Stage IIB) with 40% 5-year survival. Fifty patients had re

Prognostic value of insulinlike growth f
✍ S Moller; U Becker; A Juul; N E Skakkebaek; E Christensen πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

cant independent prognostic value. Because IGF-I and Insulinlike growth factor I (IGF-I) is a single-polypep-IGFBP-3 were closely correlated, they contained almost tide chain with important anabolic and endocrine activithe same prognostic information. Inclusion of IGF-I gave ties. The liver is the m